SOMERSET, N.J., July 07, 2016 (GLOBE NEWSWIRE) -- MTBC (Nasdaq:MTBC), a leading provider of cloud-based practice management and healthcare information technology solutions today announced that it filed a preliminary prospectus supplement (the “Prospectus”) to sell up to 63,040 additional shares of its non-convertible 11% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock,”), which was first sold to the public on November 4, 2015. The securities are being offered pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission and declared effective May 9, 2016. The Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
Dividends on the Series A Preferred Stock are payable in cash monthly on a cumulative basis when, as and if declared by the Company's board of directors, at the rate of 11% per annum of the $25.00 per share liquidation preference (equivalent to $2.75 per annum per share). The Series A Preferred Stock is not convertible, has no maturity date and is not subject to any sinking fund or mandatory redemption. Shares are subject to optional redemption by MTBC after November 4, 2020, and upon the occurrence of a change of control. The terms of the Series A Preferred Stock are described in more detail in the Prospectus.
Boenning & Scattergood, Inc. is acting as lead book-running manager for the offering. Chardan Capital Markets, LLC is serving as financial advisor to the Company.
The net proceeds of the Offering will be used to fund acquisitions and growth, as well as for working capital and other general corporate purposes, as described in the Prospectus.
Interested parties should read the Prospectus and the other documents that MTBC has filed with the Securities and Exchange Commission that are incorporated by reference into the Prospectus for more complete information. Copies of the applicable prospectus relating to the offering may be obtained when available by contacting Boenning & Scattergood, Inc., 4 Tower Bridge, 200 Barr Harbor Drive, Suite 300, West Conshohocken, PA 19428-2979, or by visiting the Commission’s website at http://www.sec.gov.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein or any other securities, nor shall there be any sale of these notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “when”" “if” anticipate," "believe," "continue," "could," "estimate," "expect," "goals," "intend," "likely," "may," "plan," "potential," "predict," "project," "will," "might," "would," "consider", "see," "think," or the negative of these terms or other similar terms and phrases.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include, but are not limited to, the Company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Investor Contact:
PCG Advisory Group
Christine J. Petraglia
Managing Director
Christine@pcgadvisory.com
(646) 731-9817
Media Contact:
PCG Advisory Group
Sean Leous
Chief Communications Officer
sleous@pcgadvisory.com
(646) 863-8998
Company Contact:
Bill Korn,
Chief Financial Officer
MTBC
bkorn@mtbc.com
(732) 873-5133